BCM
STIM icon

Bluefin Capital Management’s Neuronetics STIM Stock Holding History

Bluefin Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,937
Closed -$28.9K – 219
2025
Q4 		$28.9K Sell
20,937
-21,768
-51% -$45.5K 0.01% 158
2025
Q3 		$117K Buy
+42,705
New +$152K 0.04% 57

Other funds holding STIM

MAM
Madryn Asset Management New York $34.1M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bluefin Capital Management's STIM Position: Q1 2026 in Review

Bluefin Capital Management sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 20,937 shares — an estimated $28.9K sold.

Bluefin Capital Management first reported a position in STIM in Q3 2025 and held it in 2 quarters. The position peaked at $117K in Q3 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Bluefin Capital Management reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
  • Bluefin Capital Management sold 20,937 Neuronetics shares in Q1 2026, an estimated $28.9K.
  • Bluefin Capital Management first reported a position in Neuronetics in Q3 2025 and held it in 2 quarters.
  • Bluefin Capital Management's Neuronetics position peaked at $117K in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.